AI-generated summary
The authors studied whether low power laser treatment of the retina could reduce abnormal blood vessel growth in a transgenic mouse model. Treated eyes showed significantly less neovascularisation than untreated eyes, with comparable electroretinogram responses, suggesting partial preservation of visual function. The study used mice, so the findings may not directly apply to humans.
- Who or what was studied
- Transgenic mice with retinal neovascularisation
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The study was conducted in a transgenic mouse model, and the abstract reports only partial photoreceptor loss in treated eyes without a stated total sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm
- Power
- 20 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.